Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ev3 Rises Above IPO Device Class of 2005

This article was originally published in Start Up

Executive Summary

Covidien's acquisiton of ev3 is cause for a review of the dozen device companies that went public in 2005.

You may also be interested in...



Covidien Runs Familiar But Different Plays to Build Vascular Franchise

Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.

Vnus Buy Latest Big Win for 2004 Device IPO Class

The medical device industry broke the IPO ice in 2004, sending 17 companies onto the US public markets. How have they fared?

Covidien Set to Compete in Vascular Business

Covidien, following the acquisition of Vnus Medical Technologies and Bacchus Vascular, is establishing a global business unit focused on vascular surgery.

Related Content

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091988

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel